Showing results (231-240 of 262) with videos related to
Sort By:
Pageof 27
American Journal of Hypertension|September 10, 1999
Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rateW B White, G A Mansoor, T G Pickering, et al.Cancer|April 7, 1998
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaK Antman, J Crowley, S P Balcerzak, et al.Journal of Human Hypertension|March 22, 2013
Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramiprilG Bönner, G L Bakris, D Sica, et al.American Journal of Clinical Oncology|October 1, 1986
High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicitiesC Karanes, V Ratanatharathorn, R B Schilcher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.Cytometry|January 1, 1993
DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissueM M Zalupski, Z Maciorowski, J R Ryan, et al.Cancer Treatment Reports|October 1, 1980
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot studyL P Leichman, L H Baker, C R Stanhope, et al.Investigational New Drugs|January 1, 1990
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group studyW A Knight, P Goodman, S A Taylor, et al.Investigational New Drugs|January 1, 1983
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group studyF E Smith, N Gad-el-Mawla, B Tranum, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2000
Reproducibility of ambulatory blood pressure monitoring in hemodialysis patientsA J Peixoto, S F Santos, R B Mendes, et al.Pageof 27